Royal Bank Of Canada Vbi Vaccines Inc Transaction History

Royal Bank Of Canada

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.29 - $0.64 $4,313 - $9,518	-14,873 Reduced 38.13%	24,128 $7,000
Q4 2022 Feb 14, 2023	BUY	$0.38 - $22.5 $8,966 - $530,910	23,596 Added 153.17%	39,001 $15,000
Q3 2022 Nov 14, 2022	BUY	$0.73 - $23.4 $421 - $13,525	578 Added 3.9%	15,405 $11,000
Q2 2022 Aug 15, 2022	BUY	$0.66 - $1.81 $1,187 - $3,256	1,799 Added 13.81%	14,827 $12,000
Q1 2022 May 16, 2022	SELL	$1.27 - $2.47 $38,407 - $74,697	-30,242 Reduced 69.89%	13,028 $21,000
Q4 2021 Feb 14, 2022	BUY	$2.21 - $3.22 $53,086 - $77,347	24,021 Added 124.79%	43,270 $101,000
Q3 2021 Nov 15, 2021	SELL	$2.8 - $3.72 $27,798 - $36,932	-9,928 Reduced 34.03%	19,249 $59,000
Q2 2021 Aug 16, 2021	BUY	$2.61 - $4.17 $76,151 - $121,668	29,177 New	29,177 $98,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.